Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (611-620 of 759) with videos related to

Pageof 76
Sort By:
American Journal of Hematology|April 17, 2018
Time to plateau as a predictor of survival in newly diagnosed multiple myelomaPatrick W Mellors, Moritz Binder, Francis K Buadi, et al.
Mayo Clinic Proceedings|October 3, 2008
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiativeMorie A Gertz, Stephen M Ansell, David Dingli, et al.
Mayo Clinic Proceedings|February 3, 2009
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative componentJohn A Lust, Martha Q Lacy, Steven R Zeldenrust, et al.
Blood Cancer Journal|December 12, 2023
Muscle and fat composition in patients with newly diagnosed multiple myelomaNadine H Abdallah, Hiroki Nagayama, Naoki Takahashi, et al.
Blood Advances|August 21, 2023
Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapyCharalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
American Journal of Hematology|September 30, 2017
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL)Nidhi Tandon, Surbhi Sidana, Angela Dispenzieri, et al.
Frontiers in Endocrinology|July 8, 2022
Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal OutcomeEli Muchtar, Matthew T Drake, Nelson Leung, et al.
Human Pathology|November 18, 2023
Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic diseaseSarwat I Gilani, Surendra Dasari, Burak Tekin, et al.
Blood Cancer Journal|August 30, 2020
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myelomaAshley Paquin, Alissa Visram, Shaji K Kumar, et al.
Leukemia|November 30, 2019
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological featuresSurbhi Sidana, Daniel P Larson, Patricia T Greipp, et al.
Pageof 76

Showing results (611-620 of 759) with videos related to

Sort By:
Pageof 76
American Journal of Hematology|April 17, 2018
Time to plateau as a predictor of survival in newly diagnosed multiple myelomaPatrick W Mellors, Moritz Binder, Francis K Buadi, et al.
Mayo Clinic Proceedings|October 3, 2008
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiativeMorie A Gertz, Stephen M Ansell, David Dingli, et al.
Mayo Clinic Proceedings|February 3, 2009
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative componentJohn A Lust, Martha Q Lacy, Steven R Zeldenrust, et al.
Blood Cancer Journal|December 12, 2023
Muscle and fat composition in patients with newly diagnosed multiple myelomaNadine H Abdallah, Hiroki Nagayama, Naoki Takahashi, et al.
Blood Advances|August 21, 2023
Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapyCharalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
American Journal of Hematology|September 30, 2017
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL)Nidhi Tandon, Surbhi Sidana, Angela Dispenzieri, et al.
Frontiers in Endocrinology|July 8, 2022
Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal OutcomeEli Muchtar, Matthew T Drake, Nelson Leung, et al.
Human Pathology|November 18, 2023
Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic diseaseSarwat I Gilani, Surendra Dasari, Burak Tekin, et al.
Blood Cancer Journal|August 30, 2020
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myelomaAshley Paquin, Alissa Visram, Shaji K Kumar, et al.
Leukemia|November 30, 2019
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological featuresSurbhi Sidana, Daniel P Larson, Patricia T Greipp, et al.
Pageof 76